Select Medical Holdings Corporation (NYSE:SEM) Given Average Recommendation of “Hold” by Brokerages

Select Medical Holdings Corporation (NYSE:SEM) has received a consensus rating of “Hold” from the seven brokerages that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $15.50.

SEM has been the topic of a number of research reports. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Mizuho reaffirmed a “neutral” rating and issued a $16.50 price objective (down from $17.00) on shares of Select Medical in a report on Tuesday, May 12th. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $16.50 price objective (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Finally, Zacks Research raised Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th.

Select Medical Stock Up 0.1%

Shares of SEM stock opened at $16.56 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15. The firm’s 50-day moving average is $16.49 and its 200-day moving average is $15.88. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of 15.62, a PEG ratio of 0.95 and a beta of 1.01. Select Medical has a 52-week low of $11.65 and a 52-week high of $16.99.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the previous year, the company posted $0.44 earnings per share. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Sell-side analysts predict that Select Medical will post 1.26 EPS for the current year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 28th. Stockholders of record on Thursday, May 14th were issued a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 14th. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. Select Medical’s dividend payout ratio (DPR) is currently 23.58%.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD increased its holdings in shares of Select Medical by 4.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 16,606,269 shares of the health services provider’s stock worth $246,604,000 after purchasing an additional 684,695 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Select Medical by 3.8% during the first quarter. Dimensional Fund Advisors LP now owns 5,536,331 shares of the health services provider’s stock worth $90,188,000 after purchasing an additional 202,736 shares during the period. State Street Corp increased its holdings in shares of Select Medical by 1.3% during the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after purchasing an additional 55,686 shares during the period. Hsbc Holdings PLC increased its holdings in shares of Select Medical by 7,554.6% during the first quarter. Hsbc Holdings PLC now owns 2,245,163 shares of the health services provider’s stock worth $36,596,000 after purchasing an additional 2,215,832 shares during the period. Finally, Western Standard LLC increased its holdings in shares of Select Medical by 95.6% during the fourth quarter. Western Standard LLC now owns 2,064,021 shares of the health services provider’s stock worth $30,651,000 after purchasing an additional 1,008,664 shares during the period. 89.48% of the stock is owned by institutional investors.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.